INDICATIONS AND CONTRAINDICATIONS TO THE APPLICATION OF NEGATIVE PRESSURE TO THE TREATMENT OF DIABETIC ULCERS AND PRESSURE ULCERS
Ariadni Antonakou, Ioannis Kalemikerakis, Maria Charcharidou, Georgios Vasilopoulos
Monday, May 1, 2017
Publication year:
2017
Authors:
- Antonakou Ariadni, RN, MSc, General Hospital of Nikaia-Piraeus “Agios Panteleimon”, Athens, Greece
- Kalemikerakis Ioannis, 2. Lecturer, Faculty of Health and Caring Professions, Department of Nursing, Athens University of Applied Sciences, Greece
- Charcharidou Maria, RN,MSc,PhD, General Hospital of Athens “G.Gennimatas”, Athens,Greece
- Vasilopoulos Georgios, Assistant Professor, Faculty of Health and Caring Professions, Department of Nursing, Athens University of Applied Sciences, Greece
Keywords index:
Pages: 96-106
Abstract:
Introduction:Clinicians treat open wounds using the negative pressure therapy for over a century. Aim: The aim of this study was to investigate the effectiveness of negative pressure systems in the treatment of diabetic foot and pressure ulcers.Methodology: This is a systematic review. It was done a thorough search in the Greek and international literature on databases indexing bibliographic data Pubmed, Cinahl, Sciverse Scopus and Proquest. Articles published in Greek and English language from 2006 until 2016 were included in the study. Results:Negative pressure wound therapy (NPWT) is effective in the treatment of diabetic foot ulcers and pressure ulcers reducing the duration of treatment and monitoring. Contraindications of negative pressure therapy includes infected wounds, uncontrolled osteomyelitis, uncontrolled bleeding, coagulopathy, malignancy, pain, non-enteric or unexplored fistulae, the presence of necrotic tissue and direct mount on the exposed structures. Before applying negative pressure, the wounds should be free of infection and/or necrotic tissue. Conclusions:It is necessary to conduct even more quantitative and qualitative studies that will completely clarify the field of treatment with negative pressure. The medical device manufacturing companies, should improve the size and autonomy of the devices in order to be more tolerated by patients and not to limit their daily lives.
Download PDF